Related Experiment Video
Updated: Jun 23, 2026

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Biological barriers to therapy with antisense and siRNA oligonucleotides
1UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27599, USA. arjay@med.unc.edu
Understanding biological barriers is key to maximizing the therapeutic potential of antisense and small interfering RNA (siRNA) oligonucleotides. This review explores delivery challenges and aids in designing better oligonucleotide delivery systems.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Delivery
Background:
- Antisense and siRNA oligonucleotides offer significant therapeutic promise.
- Realizing their full potential is hindered by biological barriers.
- Effective cellular delivery remains a challenge for oligonucleotide therapeutics.
Purpose of the Study:
- To review key biological barriers affecting oligonucleotide biodistribution.
- To examine challenges for both free and nanocarrier-associated oligonucleotides.
- To inform the design of improved oligonucleotide delivery systems.
Main Methods:
- Literature review of biological barriers impacting oligonucleotide delivery.
- Analysis of factors influencing molecular and nanocarrier-based oligonucleotide biodistribution.
- Synthesis of information on biological processes underlying delivery challenges.
Main Results:
- Identified critical biological barriers to oligonucleotide therapeutic utility.
- Discussed biodistribution challenges for oligonucleotides in free and nanocarrier forms.
- Highlighted the importance of understanding cellular barriers for effective delivery.
Conclusions:
- Overcoming biological barriers is essential for advancing oligonucleotide therapeutics.
- Knowledge of these barriers aids in the rational design of delivery vehicles.
- Improved delivery systems will enhance the clinical application of antisense and siRNA oligonucleotides.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Inhibitors of Viral Protein Synthesis
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
